Loading...
XJPX
4061
Market cap2.09bUSD
Jul 10, Last price  
3,913.00JPY
1D
-0.15%
1Q
2.68%
Jan 2017
51.67%
Name

Denka Co Ltd

Chart & Performance

D1W1MN
XJPX:4061 chart
P/E
21.49
P/S
0.88
EPS
182.08
Div Yield, %
2.56%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
1.63%
Revenues
384.25b
-4.00%
329,262,000,000363,996,000,000334,130,000,000323,875,000,000357,893,000,000364,712,000,000341,645,000,000376,809,000,000383,978,000,000369,853,000,000362,647,000,000395,629,000,000413,128,000,000380,803,000,000354,391,000,000384,849,000,000407,559,000,000389,263,000,000400,251,000,000384,247,000,000
Net income
15.70b
P
15,734,000,0006,660,000,0001,439,000,00010,474,000,00014,355,000,00011,330,000,00011,255,000,00013,573,000,00019,021,000,00019,472,000,00018,145,000,00023,036,000,00025,045,000,00022,702,000,00022,784,000,00026,012,000,00012,769,000,00011,948,000,000-12,300,000,00015,695,000,000
CFO
36.15b
+94.17%
25,064,000,00022,944,000,0005,793,000,00046,418,000,00033,780,000,00028,521,000,00040,215,000,00027,245,000,00035,557,000,00044,014,000,00039,557,000,00048,776,000,00032,660,000,00041,954,000,00040,610,000,00042,630,000,0008,946,000,00036,260,000,00018,620,000,00036,154,000,000
Dividend
Sep 29, 202650 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Denka Company Limited, an enterprise based in Tokyo, Japan, and established in 1915, operates as a global producer and purveyor of a diverse range of organic and inorganic materials. Its extensive product portfolio caters primarily to the electronics and pharmaceutical sectors. The company's operations are segmented into several key divisions. The Electronics & Innovative Products segment is dedicated to developing and supplying advanced components such as conductive agents crucial for lithium-ion batteries, along with thermal management materials, specialized substrates, high-performance ceramics, and various films and tapes. Under its Life Innovation division, Denka plays a significant role in public health, offering influenza vaccines, producing rapid diagnostic kits – including those for identifying novel coronavirus antigens – and providing macromolecular sodium hyaluronate preparations. The Elastomers & Infrastructure Solutions arm encompasses a variety of products, ranging from specialized functional elastomers and cement additives to agricultural essentials like fertilizers and corrugated pipes. Finally, the Polymer Solutions division focuses on synthetic materials, featuring styrene-based resins, food packaging sheets, and synthetic fibers utilized in wigs and hairpieces, alongside poval and other diverse chemical offerings. Originally founded in 1915 as Denki Kagaku Kogyo Kabushiki Kaisha, the company adopted its current name, Denka Company Limited, in October 2015.
IPO date
May 16, 1949
Employees
4,198
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT